X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/23/2887183/0/en/Apogee-Therapeutics-to-Participate-in-Upcoming-June-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/15/2882855/0/en/Apogee-Announces-Dosing-of-First-Patient-in-Phase-2-Atopic-Dermatitis-Trial-of-APG777-a-Novel-Subcutaneous-Half-life-Extended-Anti-IL-13-Antibody-for-the-Treatment-of-Atopic-Dermat.html
https://www.globenewswire.com/news-release/2024/05/13/2880262/0/en/Apogee-Therapeutics-Highlights-Pipeline-Progress-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/06/2875733/0/en/Apogee-Therapeutics-to-Participate-at-the-2024-Bank-of-America-Healthcare-Conference.html
https://endpts.com/apogee-spyre-founder-launches-its-third-biotech-and-heads-straight-to-nasdaq/
https://www.globenewswire.com/news-release/2024/03/25/2851495/0/en/Apogee-Therapeutics-Announces-First-Participants-Dosed-in-Phase-1-Trial-of-APG808-its-Novel-Half-life-Extended-IL-4R%CE%B1-Antibody-for-the-Treatment-of-Chronic-Obstructive-Pulmonary-Di.html
https://www.globenewswire.com//news-release/2024/03/12/2844994/0/en/Apogee-Therapeutics-Inc-Announces-Closing-of-Upsized-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares-for-Gross-Proceeds-of-483-Million.html
https://investors.apogeetherapeutics.com/news-releases/news-release-details/apogee-therapeutics-inc-announces-pricing-upsized-420-million
https://finance.yahoo.com/m/f4593c39-5eff-3ad4-9fbd-b9eb6772e4be/apogee-catapults-42-after.html
https://www.globenewswire.com//news-release/2024/03/05/2840924/0/en/Apogee-Therapeutics-Inc-Announces-Proposed-Underwritten-Public-Offering.html
Market Place
Share 
